Axa lowered its position in shares of Aetna Inc. (NYSE:AET) by 7.9% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 235,738 shares of the company’s stock after selling 20,095 shares during the period. Axa owned about 0.07% of Aetna worth $35,792,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. FTB Advisors Inc. boosted its position in Aetna by 11.0% during the 1st quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC purchased a new stake in Aetna during the 1st quarter valued at $133,000. Liberty Capital Management Inc. boosted its position in Aetna by 206.9% during the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares during the period. Guardian Life Insurance Co. of America boosted its position in Aetna by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares during the period. Finally, Advisory Services Network LLC purchased a new stake in Aetna during the 1st quarter valued at $195,000. 89.58% of the stock is owned by institutional investors and hedge funds.

AET has been the subject of several analyst reports. Stifel Nicolaus increased their price target on shares of Aetna from $150.00 to $158.00 and gave the company a “buy” rating in a research report on Tuesday, May 16th. Royal Bank Of Canada increased their price target on shares of Aetna from $147.00 to $162.00 and gave the company an “outperform” rating in a research report on Friday, June 9th. BidaskClub cut shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Deutsche Bank AG increased their price target on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research report on Monday, August 7th. Finally, UBS AG reissued a “buy” rating and set a $160.00 price target (up previously from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $157.99.

Shares of Aetna Inc. (NYSE AET) traded up 0.92% on Friday, hitting $161.73. 478,939 shares of the company traded hands. The firm’s 50-day moving average is $156.07 and its 200 day moving average is $143.71. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $162.30. The firm has a market capitalization of $53.71 billion, a P/E ratio of 35.90 and a beta of 0.53.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. During the same period in the prior year, the firm earned $2.21 earnings per share. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, analysts anticipate that Aetna Inc. will post $9.54 earnings per share for the current fiscal year.

WARNING: “Axa Has $35.79 Million Holdings in Aetna Inc. (AET)” was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://theolympiareport.com/2017/09/08/axa-has-35-79-million-holdings-in-aetna-inc-aet.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.